BNP PARIBAS FINANCIAL MARKETS - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 39 filers reported holding NEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$6,000
+20.0%
100.0%0.00%
Q3 2020$5,000
-97.2%
10
-96.2%
0.00%
Q2 2020$178,000
-8.7%
2600.0%0.00%
Q1 2020$195,000
-50.4%
2600.0%0.00%
Q4 2019$393,000
-95.2%
260
-95.3%
0.00%
Q3 2019$8,176,000
+14.7%
5,5240.0%0.00%
Q2 2019$7,126,000
-73.0%
5,524
-45.3%
0.00%
Q1 2019$26,356,000
+2825.2%
10,098
+1749.5%
0.00%
Q4 2018$901,000
-80.9%
546
-43.8%
0.00%
Q3 2018$4,714,000
-22.4%
9720.0%0.00%
Q2 2018$6,075,000
-86.5%
972
-82.1%
0.00%
Q1 2018$45,036,000
-15.1%
5,426
+4.3%
0.00%
Q4 2017$53,071,000
+290.3%
5,203
+250.1%
0.00%
Q3 2017$13,597,000
+14.8%
1,486
-8.4%
0.00%
Q2 2017$11,841,000
+2151.1%
1,622
+2121.9%
0.00%
Q1 2017$526,000
-87.0%
73
-89.4%
0.00%
Q4 2016$4,031,000
-27.0%
689
-17.9%
0.00%
Q3 2016$5,521,000
+8.6%
839
+53.1%
0.00%
Q2 2016$5,085,000
+2254.2%
548
+2640.0%
0.00%
Q1 2016$216,000
-98.5%
20
-98.0%
0.00%
Q4 2015$14,234,000
-33.8%
994
-2.9%
0.00%
Q3 2015$21,514,0001,0240.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders